Although the effects of L-arginine in increasing NO synthesis and eNOS expression, and attenuating pulmonary hypertension have been previously studied [19, 24], the effects of NCG on alleviating HAPH remain unknown. The gene discussed is NOS3; the disease is pulmonary arterial hypertension.